Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01630421 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

Study acronym: ACC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2025 to Dec 2030v14
  2. 11 versions Re-verified since Aug 27, 2013, no change to tracked fieldsv3-v13
  3. Study Status, Study Design, Outcome Measuresv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
UConn Health
38 trials monitored
See 2 trials at risk
The goal of this research study is to identify genes and regulatory elements on chromosomes that cause ACC. The investigators also study tissue samples from patients to learn about the processes that lead to this disorder.
Trial Details
NCT Number NCT01630421
Lead Sponsor UConn Health
Conditions
(from sponsor)		 Aplasia Cutis Congenita
Related terms Ectodermal Dysplasia
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov